The announcement of a class action lawsuit against Taro Pharmaceutical Industries Ltd. is likely to negatively impact the stock price in the short term due to potential legal liabilities and negative investor sentiment. The lawsuit involves the company and certain officers, which could raise concerns about corporate governance and financial stability.